Medifast, Inc. (LON:0K05)

Medifast Statistics

Total Valuation

Medifast has a market cap or net worth of GBP 88.87 million. The enterprise value is -33.66 million.

Market Cap	88.87M
Enterprise Value	-33.66M

Important Dates

The last earnings date was Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	10.28M
Shares Outstanding	n/a
Shares Change (YoY)	+0.27%
Shares Change (QoQ)	-0.62%
Owned by Insiders (%)	3.01%
Owned by Institutions (%)	84.85%
Float	9.17M

Valuation Ratios

The trailing PE ratio is 481.69.

PE Ratio	481.69
Forward PE	n/a
PS Ratio	0.28
PB Ratio	0.56
P/TBV Ratio	0.56
P/FCF Ratio	184.92
P/OCF Ratio	16.61
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-182.44
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-70.04

Financial Position

The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.06.

Current Ratio	4.45
Quick Ratio	3.71
Debt / Equity	0.06
Debt / EBITDA	0.48
Debt / FCF	18.98
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 0.12% and return on invested capital (ROIC) is 1.88%.

Return on Equity (ROE)	0.12%
Return on Assets (ROA)	1.52%
Return on Invested Capital (ROIC)	1.88%
Return on Capital Employed (ROCE)	3.07%
Revenue Per Employee	634,261
Profits Per Employee	366
Employee Count	504
Asset Turnover	1.54
Inventory Turnover	3.74

Taxes

In the past 12 months, Medifast has paid 1.32 million in taxes.

Income Tax	1.32M
Effective Tax Rate	87.71%

Stock Price Statistics

The stock price has decreased by -42.57% in the last 52 weeks. The beta is 0.50, so Medifast's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-42.57%
50-Day Moving Average	13.17
200-Day Moving Average	13.70
Relative Strength Index (RSI)	30.23
Average Volume (20 Days)	503

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	12.82

Income Statement

In the last 12 months, Medifast had revenue of GBP 319.67 million and earned 184,497 in profits. Earnings per share was 0.01.

Revenue	319.67M
Gross Profit	231.56M
Operating Income	5.06M
Pretax Income	1.50M
Net Income	184,497
EBITDA	15.45M
EBIT	5.06M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 129.08 million in cash and 9.12 million in debt, giving a net cash position of 119.96 million.

Cash & Cash Equivalents	129.08M
Total Debt	9.12M
Net Cash	119.96M
Net Cash Per Share	n/a
Equity (Book Value)	159.73M
Book Value Per Share	15.54
Working Capital	119.87M

Cash Flow

In the last 12 months, operating cash flow was 5.35 million and capital expenditures -4.87 million, giving a free cash flow of 480,585.

Operating Cash Flow	5.35M
Capital Expenditures	-4.87M
Free Cash Flow	480,585
FCF Per Share	n/a

Margins

Gross margin is 72.44%, with operating and profit margins of 1.58% and 0.06%.

Gross Margin	72.44%
Operating Margin	1.58%
Pretax Margin	0.47%
Profit Margin	0.06%
EBITDA Margin	4.83%
EBIT Margin	1.58%
FCF Margin	0.15%

Dividends & Yields

Medifast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	78.63%
Buyback Yield	-0.27%
Shareholder Yield	-0.27%
Earnings Yield	0.21%
FCF Yield	0.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medifast has an Altman Z-Score of 5.12 and a Piotroski F-Score of 5.

Altman Z-Score	5.12
Piotroski F-Score	5